Connect with uBriGene at The Advanced Therapies USA 2025

November 18, 2025

Meet uBriGene in Philadelphia: Driving the Future of Cell and Gene Therapy at The Advanced Therapies Congress 2025

Philadelphia, PA - November 18–19, 2025 - uBriGene Biosciences is excited to participate in The Advanced Therapies Congress 2025, one of America’s premier cell and gene therapy (ATMP) conferences. The event will bring together 1,200+ global leaders, 200 speakers, and 50 start-ups at the Pennsylvania Convention Center to explore the latest technologies, strategies, and innovations in cell and gene therapy.

Visit uBriGene at Booth #600

Attendees are invited to meet the uBriGene team and explore our latest advancements in ATMP development, including:

An Innovative mRNA-LNP Kit for iPSC Reprogramming from PBMC
Characterization of GMP-Compliant iPSC Master Cell Bank for Clinical Applications
Lentiviral Vector Manufacturing Platform featuring a closed down-stream process and 4+1 system, reducing production cost to $100 per CAR-T dose.

📅 November 19, 2025 | 10:25 – 11:00 AM

Our participation in The Advanced Therapies Congress 2025 demonstrates our commitment to advancing cell and gene therapy solutions and collaborating with global leaders in the ATMP ecosystem. We look forward to connecting with industry partners, sharing our innovations, and contributing to the future of advanced therapies.

Visit uBriGene at Booth #600 to learn more about our latest developments in mRNA-LNP kits, iPSC technologies, and lentiviral vector manufacturing. Schedule a partnering meeting with our team here.